Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy
| Status: | Completed |
|---|---|
| Conditions: | Lung Cancer, Cancer, Chronic Pain |
| Therapuetic Areas: | Musculoskeletal, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/14/2016 |
| Start Date: | December 2014 |
| End Date: | October 2015 |
A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer
This pilot clinical trial studies a pain management smartphone application for monitoring
pain in patients with locally advanced head and neck cancer who are undergoing radiation
therapy. The study is also open to patients with esophageal or lung cancer. A smartphone
application may allow patients to assess their symptoms in a manner that is closer to
real-time than having to recall pain episodes during once weekly on-treatment visits with a
health care provider. This real-time monitoring may improve the timing and efficacy of
interventions leading to better pain-control and quality of life.
pain in patients with locally advanced head and neck cancer who are undergoing radiation
therapy. The study is also open to patients with esophageal or lung cancer. A smartphone
application may allow patients to assess their symptoms in a manner that is closer to
real-time than having to recall pain episodes during once weekly on-treatment visits with a
health care provider. This real-time monitoring may improve the timing and efficacy of
interventions leading to better pain-control and quality of life.
PRIMARY OBJECTIVES:
I. Obtain consumer input to determine the optimal way to address and monitor the patient's
symptoms.
II. Train patients to use the pain management smartphone application (PMSA) and determine
the compliance characteristics and the number of additional on-treatment visits (OTVs)
prompted by usage of the application.
OUTLINE:
Selected patients are interviewed for input that will help guide the wording of questions of
the PMSA. All patients/caregivers are then instructed to download the PMSA and are
demonstrated how to properly use the application. Beginning on the first day of radiation
therapy (day 1), patients are instructed to use the PMSA for the duration of their radiation
therapy (up to day 50), although the timing may change based on the availability of the app.
I. Obtain consumer input to determine the optimal way to address and monitor the patient's
symptoms.
II. Train patients to use the pain management smartphone application (PMSA) and determine
the compliance characteristics and the number of additional on-treatment visits (OTVs)
prompted by usage of the application.
OUTLINE:
Selected patients are interviewed for input that will help guide the wording of questions of
the PMSA. All patients/caregivers are then instructed to download the PMSA and are
demonstrated how to properly use the application. Beginning on the first day of radiation
therapy (day 1), patients are instructed to use the PMSA for the duration of their radiation
therapy (up to day 50), although the timing may change based on the availability of the app.
Inclusion Criteria:
- Radiation oncology patients undergoing 5-7 weeks of definitive radiation therapy for
head and neck, esophageal or lung cancer.
- Ability to understand and the willingness to use the PMSA on the patient's personal
smartphone
- Displays ability to use and understand the PMSA as evidenced by successful response
to alarm and successful entries while monitored by the principal investigator (PI)
- Willing and able to provide informed consent and fill out demographic, disease, and
pain assessment questionnaires
- English speaking
Exclusion Criteria:
- Radiation oncology patients undergoing palliative courses of radiation
- Patients who do not own smartphones
- Patients who are unable to successfully respond to the PMSA alarm and properly enter
their data
- Patients who are unable to eat and drink normally
- Patients who are unable to validate their understanding of the pain scale
We found this trial at
1
site
Vanderbilt-Ingram Cancer Center The Vanderbilt-Ingram Cancer Center, located in Nashville, Tenn., brings together the clinical...
Click here to add this to my saved trials
